scholarly journals COVID-19 Vaccination Efforts: Is Afghanistan Prepared?

Author(s):  
Mohammad Faisal Wardak ◽  
Ali Rahimi ◽  
Attaullah Ahmadi ◽  
Shekiba Madadi ◽  
Shamim Arif ◽  
...  

A country’s preparedness for a prompt and successful implementation of vaccination programs plays a pivotal role in disease control and prevention. As it stands now, Afghanistan seems to be ill-prepared to embrace a successful implementation of the COVID-19 vaccination program because of a spate of challenges. These include, but are not limited to, the insufficient number of vaccinators, a dearth of fully integrated functioning cold chain, challenging geographical barriers, cultural issues, insecurity, and protracted conflict. The COVID-19 infodemic along with vaccine mistrust in the country will lead to a pervasive public vaccine hesitancy in Afghanistan, which will present serious obstacles to the COVID-19 immunization efforts. The politicization of the Ministry of Public Health (MoPH) and the complaints of embezzlement and misuse of the pandemic aid have already eroded public trust during the pandemic. To ensure a large-scale and equitable distribution of COVID-19 vaccines, the cold chain infrastructure should be strengthened, and the immunization personnel trained. Antivaccination propaganda and misinformation should be tackled with effective communication approaches and effective community engagement, which consider culturally relevant messages appropriate to the culture and people. The allegations of corruption should be addressed to revive public trust in public health interventions, including COVID-19 vaccination.

2021 ◽  
Vol 2 (1) ◽  
pp. 41-46
Author(s):  
Aleksandr N. Tsibin ◽  
Munira F. Latypova ◽  
Olga I. Ivanushkina

Introduction. Transmissible coronavirus SARS-CoV-2I is the seventh known coronavirus that causes an acute infectious disease predominantly affecting the lungs (Corona Virus Disease 2019, COVID-19). The COVID-19 pandemic exposed serious gaps in health systems preparedness. The epidemic urgently required priority organizational measures to contain and reduce the spread of COVID-19. Public health authorities had to make decisions in a challenging situation where there was a lack of knowledge, experience, and great confidence, and the number of infected was steadily increasing. Purpose. The purpose of this article is to present the unique experience of Moscow in organizing a large-scale laboratory examination of the population of a metropolis with about 12.6 million inhabitants to meet the needs of the capital in testing for SARS-CoV-2 virus and combating its circulation in conditions of the COVID-19 pandemic. Materials and Methods. The decisions made and the measures taken by the Government of Moscow, the Moscow Operational Staff, the DZM and the DZM Laboratory Service to slow the growth of the COVID-19 epidemic among the population of the capital are listed step-by-step. Results. In the course of organizational activities, sufficient capacity to maintain the public health infrastructure in terms of laboratory diagnosis of the new coronavirus infection was ensured by the joint efforts. Safe laboratory diagnostics for detecting, treating, and isolating COVID-19 cases and contacts have been established in the capital city. Thanks to the successful implementation of timely decisions, the spread of infection in the city of Moscow has been slowed. The Moscow government has reported a steady decline in cases of the new coronavirus disease and most hospitals have switched to a safe treatment regimen for patients requiring hospitalization. Centralized laboratories with readiness to perform screening and referral studies for COVID-19 outbreaks have been established within the structure of the DZM.


2011 ◽  
Vol 26 (S1) ◽  
pp. s59-s59
Author(s):  
A.E. Piombino

This session offers an overview of the Strategic National Stockpile (SNS) and the Cities Readiness Initiative (CRI), including CHEM PACK. Managed by the US Department of Health and Human Services Centers for Disease Control and Prevention (CDC), “push-packs” of this critical federal cache of pharmaceuticals and medical materiel are at sites located throughout the country. The CDC's CRI is a federally funded program designed to compliment the SNS and enhance preparedness in the nation's largest cities and Metropolitan Statistical Areas (MSA) where more than 50% of the US population resides. Through CRI, state and large metropolitan public health departments continue refining plans to respond to a large-scale bioterrorism attack by dispensing antibiotics to the entire population of an identified MSA with 48 hours. The SNS Technical Assistance Review (TAR) will be reviewed, as well as best practices and lessons learned from successful public health emergency preparedness and response programs throughout the US.


Author(s):  
Serhat Sirekbasan

I would like to mention an issue discussed constantly these days in the light of scientific data. It would be best to start by answering a question everyone is curious about before we start the main topic. Will this virus go away? The answer is simply “No”. The virus will probably continue to exist together with us; however, one day, the pandemic will end. The only answer we can give to the question of how this pandemic will end is “scientific and social fight”. All countries throughout the entire world are fighting to control the spread of SARS-CoV-2. The most important among these global fights is proper medical treatment in addition to an early, rapid and accurate diagnosis. Besides, another aspect that will crown this fight is the vaccination programs. The success of this fight depends on people’s accepting the vaccines. A total of 10 of the vaccine candidates, which numbered more than 165 developed within a record time period, have achieved approval after their final stages of effectiveness tests on a large scale as of March when the whole world mobilized to produce vaccines to stop the pandemic. Unfortunately; however, a vaccine against COVID-19 is unlikely to provide full protection. Also, even if a safe and effective vaccine comes to be known, it will not be possible to reach adequate distribution worldwide within a short time period. It is estimated that the time for the distribution of a safe and effective vaccine to the population will be between the end of 2020 and early 2022. However, even in the presence of adequate vaccines, vaccination of a sufficient number of population cannot be guaranteed due to hesitations, indecisiveness, and oppositions to the vaccine. Although vaccination is considered to be one of the most successful public health measures, an increasingly growing number of people perceive it as unsafe and unnecessary. The lack of trust in vaccines comes before us as a threat to the success of vaccination programs. Hesitation, indecision, and opposition to vaccines is an extremely important issue and requires to be dealt with. As a matter of fact, vaccines, which save approximately 2-3 million lives each year, are among the greatest achievements of the past two centuries. Vaccines, which eliminated the smallpox disease successfully, also reduced the prevalence of many important diseases greatly, such as polio and measles. Today, more than 30 infectious diseases can be controlled on a worldwide scale with the existing licensed vaccines; and it is prevented that the limited public healthcare resources are spent in vain by decreasing the burden of infectious diseases that are preventable with vaccines on the healthcare system. The way to eliminate the detrimental effects of this pandemic depends on the implementation of effective and safe vaccines as soon as possible, and on maintaining this at high rates. An overall “herd immunity”, which will be achieved with high vaccination rates, will also limit the ability of the virus to spread. Of course, how long the protective immunity to vaccines will last will determine our future regarding the virus; however, it must be kept in mind that the uncertainty we are experiencing now regarding the condition of the pandemic stems from our attitudes about vaccine rejection rather than the immune response. In conclusion, the potential of vaccines to prevent diseases and save lives has never been more remarkable throughout history. However, the magnitude of the hesitations regarding the vaccines was not at such dimensions. As misinformation about vaccines spreads, public confusion also increases, and various hesitations occur against the vaccine. These hesitations prevent the success of scientists and the attempts to spread the vaccine. Attention should be paid not to spread misguiding information regarding the safety and effectiveness of immunization, explanations that may be misunderstood of especially those who do not know about the subject should be prevented, and necessary information should be provided regularly regarding the concerns of the public. In any case, the potential benefit of the existing effective vaccines depends on the adequate acceptance of them by society. For this reason, the most important task that stands out before us is to raise public awareness by informing society to eliminate hesitations regarding the vaccines to increase vaccine adaptation rates in the entire population.


Vaccines ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 62
Author(s):  
Barbaros Eroglu ◽  
Rina Fajri Nuwarda ◽  
Iqbal Ramzan ◽  
Veysel Kayser

The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize the effects of this pandemic. Drastic public health measures were put into place to stop the spread of the virus, with the hope that vaccines would be available soon. Thanks to the extraordinary commitments of many organizations and individuals from around the globe and the collaborative effort of many international scientists, vaccines against COVID-19 received regulatory approval for emergency human use in many jurisdictions in less than a year after the identification of the viral sequence. Several of these vaccines have been in use for some time; however, the pandemic is still ongoing and likely to persist for the foreseeable future. This is due to many reasons including reduced compliance with public health restrictions, limited vaccine manufacturing/distribution capacity, high rates of vaccine hesitancy, and the emergence of new variants with the capacity to spread more easily and to evade current vaccines. Here we discuss the discovery and availability of COVID-19 vaccines and evolving issues around mass vaccination programs.


2021 ◽  
Vol 26 (Supplement_1) ◽  
pp. e58-e59
Author(s):  
Jordan Yeo ◽  
Caitlyn Gudmundsen ◽  
Sajjad Fazel ◽  
Alex Corrigan ◽  
Madison Fullerton ◽  
...  

Abstract Primary Subject area Public Health and Preventive Medicine Background As Canada embarks on its rollout of the COVID-19 vaccine, vaccine hesitancy has the potential to hamper success of the vaccination campaign. Multiple surveys show that the number of Canadians willing to take the vaccine is insufficient to achieve herd immunity. Therefore, governments and health agencies are looking for solutions to increase vaccination uptake. Obtaining a better understanding of the perspective of those who are vaccine-hesitant is critical to developing successful implementation strategies for COVID-19 vaccination. Objectives To explore COVID-19 vaccination determinants among hesitant caregivers and describe categories of COVID-19 vaccine hesitancy. Design/Methods We conducted 23 semi-structured telephone interviews with parents recruited from a tertiary pediatric care centre. Seventeen participants had previously attended a specialty clinic to discuss vaccine hesitancy; the remaining were recruited from an infectious diseases follow-up clinic. The interview guide was structured around the Theoretical Domains Framework, assessing 14 behavioural constructs to identify specific determinants that guide behaviour change. Interviews were audio-recorded, transcribed, and analyzed by two independent data coders using a pragmatic inductive approach. Recurring themes were noted among subgroups of participants, who were subsequently divided into categories based on their underlying concerns. Results Five archetypes of vaccine-hesitant caregivers emerged in our data (Table 1). 1). “Bubble Dwellers” perceive themselves to be safe by following public health recommendations, and distinguish themselves from higher-risk groups to whom the vaccine should first be offered. 2). “Worriers and Delayers” identify the pandemic as a threat and are generally supportive of vaccines, but are concerned about side effects and issues surrounding vaccine development and prefer to delay vaccination. 3). “Need-for-Normals” are more concerned about social isolation and the economy than the direct effects of the COVID-19 virus, but express that the idea of a “return to normal” may sway their opinions regarding the vaccine. 4). “Exceptionalists” hold personal misperceptions of vaccine contraindications due to comorbidities or previous experiences with vaccination, and are concerned that the current rollout invokes a “one size fits all” model that does not apply to their circumstances. 5. “Freedom Fighters” view the pandemic as a hoax, are anti-establishment, and believe the information they have been provided is not convincing for them to adopt the vaccine. Conclusion The evolving pandemic provides a unique opportunity to understand determinants of vaccination intention in the vaccine hesitant population. Our qualitative study is unique in that we were able to draw upon pre-identified vaccine hesitant individuals to explore their perspectives around COVID-19 immunization. We propose that rather than viewing these individuals as one homogenous group, policymakers and health professionals address these discrete subgroups with specific communication tools and information. We are hopeful that our results will help tailor implementation strategies that are targeted to different vaccine hesitancy archetypes, as the vaccine is made available to the general public in the coming year.


2021 ◽  
Vol 6 (10) ◽  
pp. e006066
Author(s):  
Stacy Wood ◽  
Muhammad Ali Pate ◽  
Kevin Schulman

In 2021, many countries have begun distribution of COVID-19 vaccines but are hampered by significant levels of vaccine hesitancy or apathy. Experts recommend that standard health communication campaigns be expanded to include a more holistic approach of behaviourally oriented strategies. We constructed a large-scale Delphi panel of marketing and behavioural science university faculty to assess 12 previously reported US vaccination promotion strategies, asking respondents to assess applicability of the strategy in their country, how efficacy might compare to the USA and recommendations for local adaptations necessary to successful implementation. Separately, we sought to determine whether strategies based on cognitive mechanisms (eg, ‘nudges’) are more readily generalisable than strategies based on social identity. Ninety-two marketing and behavioural science faculty from universities worldwide participated. Globally, all 12 behavioural strategies were validated; a majority of respondents reported that they would or could work well in their country. While all strategies were strongly validated at a global level, specific need for regional adaptation was identified. Also, open-ended responses suggested the addition of three emergent strategies to a global effort. Finally, we see that strategies based on some types of cognitive mechanisms are more readily generalisable across regions than mechanisms based on social identity, however, this is not always true of ‘nudge’ strategies. All 12 strategies are robust to global use and consensus exists on adaptation for optimal efficacy in different regions; specific strategy recommendations are posited. Use of these strategies can accelerate individual country efforts to achieve desired vaccination rates to protect global public health.


2021 ◽  
Vol 7 (6) ◽  
pp. 5151-5160
Author(s):  
Wang Ping ◽  
Cong Jun ◽  
LiLi

Objectives: As the Coronavirus disease 2019 (COVID-19) continues to spread and smokeless sports influences sports, large-scale sporting events fascinate international and national host-country athletes and millions of travelers, which has a profound impact on large-scale sports events. Based on the methods of literature, case analysis and induction, this paper analyzes the experience of holding smokeless large-scale sports events in the context of PHEIC through the epidemic background, the measures taken by countries and the results of holding large-scale sports events. The result shows that countries took measures to strengthen surveillance of infectious diseases and be fully prepared for any incident during PHEIC. Though it may need added resources and support, these endeavors were beneficial and formed part of the experience of major events. The successful experience of holding smokeless large-scale sports events in the context of PHEIC should not dissipate with the epidemic abating, but should actively upgrade theconcept of crisis management and explore the development path of smoke-free sports events. The path includes the following: International cooperation is the key to the success of large-scale sports events and potential intervention is an effective means to prevent the spread of epidemics. Risk communication provides effective guidance for the evolution of control and prevention of epidemics. The use of digital technology to monitor the outbreak of diseases in sports activities brings new opportunities for the public health prevention and treatment system, aiming to provide support for today's sports events, and then promote the construction of emergency prevention and control systems for large-scale sports events under the trend of globalization and normalization of the epidemic situation.


2002 ◽  
Vol 30 (2) ◽  
pp. 262-266 ◽  
Author(s):  
Heather H. Horton ◽  
James J. Misrahi ◽  
Gene W. Matthews ◽  
Paula L. Kocher

Before September 11, 2001, a mass-casualty terrorist attack on American soil was generally considered a remote possibility. Similarly, before October 4, 2001—the first confirmed case of anthrax caused by intentional release — widespread bioterrorism seemed implausible. Among the arguments that such a biological artack was unlikely included: the lack of a historical precedent; the technological and organizational challenges to acquiring and weaponizing a biological agent; and the almost universal moral opprobrium that would certainly accompany the use by terrorists of such a weapon. In the wake of September 11th and October 4th, however, many are reconsidering the likelihood of a large-scale bioterrorist attack against civilians.The Centers for Disease Control and Prevention (CDC) defines bioterrorism as the intentional release of viruses, bacteria, or toxins for the purpose of harming or killing civilian. One measurement of the public health system's level of bioterrorism preparedness is the quality and distribution of laws mandating the reporting of diseases caused by certain biological agents.


2003 ◽  
Vol 18 (4) ◽  
pp. 321-326
Author(s):  
Bruce J. Walz ◽  
Richard A. Bissell ◽  
Brian Maguire ◽  
James A. Judge

AbstractThe events of 11 September 2001 have had a profound effect on disaster planning efforts in the United States. This is true especially in the area of bioter-rorism. One of the major tenets of bioterrorism response is the vaccination of at-riskpopulations. This paper investigates the efficacy of training emergency medical services paramedics to administer vaccines in public health settings as preparation for and response to bioterrorism events and other disaster events.The concept of vaccination administration by specially trained paramedics is not new. Various programs to provide immunizations for emergency services personnel and at-risk civilian populations have been reported.Vaccination programs by paramedics should follow the guidelines of the National Vaccine Advisory Committee of the Centers for Disease Control and Prevention (CDC). Thispaper compares the seven standards of the CDC guidelines to routine paramedic practice and education. It is concluded that paramedics are adequately trained to administer vaccines. However, specific training and protocols are needed in the areas of administrative paperwork and patient education. A proposed outline for a paramedic-training program is presented.


2003 ◽  
Vol 18 (4) ◽  
pp. 321-326 ◽  
Author(s):  
Bruce J. Walz ◽  
Richard A. Bissell ◽  
Brian Maguire ◽  
James A. Judge

AbstractThe events of 11 September 2001 have had a profound effect on disaster planning efforts in the United States. This is true especially in the area of bioter-rorism. One of the major tenets of bioterrorism response is the vaccination of at-riskpopulations. This paper investigates the efficacy of training emergency medical services paramedics to administer vaccines in public health settings as preparation for and response to bioterrorism events and other disaster events.The concept of vaccination administration by specially trained paramedics is not new. Various programs to provide immunizations for emergency services personnel and at-risk civilian populations have been reported.Vaccination programs by paramedics should follow the guidelines of the National Vaccine Advisory Committee of the Centers for Disease Control and Prevention (CDC). Thispaper compares the seven standards of the CDC guidelines to routine paramedic practice and education. It is concluded that paramedics are adequately trained to administer vaccines. However, specific training and protocols are needed in the areas of administrative paperwork and patient education. A proposed outline for a paramedic-training program is presented.


Sign in / Sign up

Export Citation Format

Share Document